Price:
Rs. 27,500.00
Sample Type: Tissue
Fasting Not Required
Notes:G8235
Frequently Asked Questions (FAQ's):
What does the Glioma Basic Panel include?
The panel includes essential genetic markers commonly associated with gliomas, supporting diagnosis and therapeutic decisions.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular techniques to analyse specific gene alterations relevant to glioma classification.
Who should undergo this test?
Patients diagnosed with or suspected of having a glioma are recommended to take this panel for accurate tumour profiling.
Why is this panel important for glioma evaluation?
Genetic markers help classify gliomas, predict behaviour, and guide personalised treatment strategies.
What sample type is required for this test?
Typically, tumour tissue obtained from biopsy or surgery is analysed for genetic alterations.
How accurate are the results at Metropolis Healthcare?
Metropolis Healthcare ensures high analytical accuracy through stringent quality controls and advanced molecular testing methods.
Does this test help in treatment planning?
Yes, identifying specific mutations can help clinicians choose targeted therapies or predict response to certain treatments.
Can this panel support prognosis assessment?
Yes, the genetic findings offer valuable prognostic information to guide long-term management